Venus Concept Inc. (NASDAQ:VERO – Get Free Report) saw a significant decline in short interest during the month of November. As of November 15th, there was short interest totalling 108,600 shares, a decline of 92.5% from the October 31st total of 1,450,000 shares. Based on an average daily trading volume, of 1,780,000 shares, the short-interest ratio is presently 0.1 days. Currently, 2.6% of the company’s shares are short sold.
Insiders Place Their Bets
In related news, major shareholder Michael Willingham Masters sold 94,553 shares of the firm’s stock in a transaction dated Wednesday, October 2nd. The stock was sold at an average price of $0.53, for a total transaction of $50,113.09. Following the completion of the sale, the insider now directly owns 17,059 shares of the company’s stock, valued at approximately $9,041.27. This trade represents a 84.72 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 57.98% of the stock is currently owned by corporate insiders.
Hedge Funds Weigh In On Venus Concept
An institutional investor recently raised its position in Venus Concept stock. Masters Capital Management LLC lifted its holdings in Venus Concept Inc. (NASDAQ:VERO – Free Report) by 100.0% in the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 666,702 shares of the company’s stock after purchasing an additional 333,366 shares during the period. Masters Capital Management LLC owned approximately 10.49% of Venus Concept worth $522,000 at the end of the most recent reporting period. 87.41% of the stock is owned by institutional investors and hedge funds.
Venus Concept Stock Down 6.3 %
About Venus Concept
Venus Concept Inc, a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.
Featured Articles
- Five stocks we like better than Venus Concept
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- The Latest 13F Filings Are In: See Where Big Money Is Flowing
- What is the Shanghai Stock Exchange Composite Index?
- 3 Penny Stocks Ready to Break Out in 2025
- Trading Halts Explained
- FMC, Mosaic, Nutrien: Top Agricultural Stocks With Big Potential
Receive News & Ratings for Venus Concept Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venus Concept and related companies with MarketBeat.com's FREE daily email newsletter.